Transcription Factors Involved in Prostate Gland Adaptation to Androgen Deprivation

被引:19
|
作者
Rosa-Ribeiro, Rafaela [1 ]
Nishan, Umar [1 ]
Vidal, Ramon Oliveira [2 ]
Barbosa, Guilherme Oliveira [1 ]
Reis, Leonardo Oliveira [3 ]
Cesar, Carlos Lenz [4 ,5 ]
Carvalho, Hernandes F. [1 ,5 ]
机构
[1] Univ Estadual Campinas, Dept Struct & Funct Biol, Sao Paulo, Brazil
[2] Natl Ctr Res Energy & Mat, Lab Bioinformat, Sao Paulo, Brazil
[3] Univ Estadual Campinas, Div Urol, Sao Paulo, Brazil
[4] Univ Estadual Campinas, Dept Quantum Phys, Sao Paulo, Brazil
[5] Univ Estadual Campinas, Natl Inst Photon Appl Cell Biol INFABiC, Sao Paulo, Brazil
来源
PLOS ONE | 2014年 / 9卷 / 06期
基金
巴西圣保罗研究基金会;
关键词
VENTRAL PROSTATE; B-MYB; PROGRAMMED DEATH; CELL-CYCLE; KAPPA-B; RECEPTOR; CANCER; EXPRESSION; APOPTOSIS; PROLIFERATION;
D O I
10.1371/journal.pone.0097080
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Androgens regulate prostate physiology, and exert their effects through the androgen receptor. We hypothesized that androgen deprivation needs additional transcription factors to orchestrate the changes taking place in the gland after castration and for the adaptation of the epithelial cells to the androgen-deprived environment, ultimately contributing to the origin of castration-resistant prostate cancer. This study was undertaken to identify transcription factors that regulate gene expression after androgen deprivation by castration (Cas). For the sake of comparison, we extended the analysis to the effects of administration of a high dose of 17 beta-estradiol (E2) and a combination of both (Cas+ E2). We approached this by (i) identifying gene expression profiles and enrichment terms, and by searching for transcription factors in the derived regulatory pathways; and (ii) by determining the density of putative transcription factor binding sites in the proximal promoter of the 10 most up- or down-regulated genes in each experimental group in comparison to the controls Gapdh and Tbp7. Filtering and validation confirmed the expression and localized EVI1 (Mecom), NFY, ELK1, GATA2, MYBL1, MYBL2, and NFkB family members (NFkB1, NFkB2, REL, RELA and RELB) in the epithelial and/or stromal cells. These transcription factors represent major regulators of epithelial cell survival and immaturity as well as an adaptation of the gland as an immune barrier in the absence of functional stimulation by androgens. Elk1 was expressed in smooth muscle cells and was up-regulated after day 4. Evi1 and Nfy genes are expressed in both epithelium and stroma, but were apparently not affected by androgen deprivation.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Intermittent androgen deprivation therapy for prostate cancer
    Rashid, MH
    Chaudhary, UB
    ONCOLOGIST, 2004, 9 (03): : 295 - 301
  • [42] Androgen Deprivation in Prostate Cancer - Step by Step
    Albertsen, Peter
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (24): : 2572 - 2574
  • [43] Prostate cancer, insulin, and androgen deprivation therapy
    Stattin, P
    Kaaks, R
    BRITISH JOURNAL OF CANCER, 2003, 89 (09) : 1814 - 1815
  • [44] An update on androgen deprivation therapy for prostate cancer
    Sharifi, Nima
    Gulley, James L.
    Dahut, William L.
    ENDOCRINE-RELATED CANCER, 2010, 17 (04) : R305 - R315
  • [45] Androgen Deprivation Therapy and Prostate Cancer Duration
    Williams, Scott G.
    Pickles, Tom
    Buyyounouski, Mark K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (34) : E228 - E228
  • [46] Complications of androgen deprivation therapy in prostate cancer
    Schwandt, Anita
    Garcia, Jorge A.
    CURRENT OPINION IN UROLOGY, 2009, 19 (03) : 322 - 326
  • [47] The role of intermittent androgen deprivation in prostate cancer
    Boccon-Gibod, Laurent
    Hammerer, Peter
    Madersbacher, Stephan
    Mottet, Nicolas
    Prayer-Galetti, Tommaso
    Tunn, Ulf
    BJU INTERNATIONAL, 2007, 100 (04) : 738 - 743
  • [48] Complications of androgen deprivation therapy for prostate cancer
    Holzbeierlein, JM
    McLaughlin, MD
    Thrasher, JB
    CURRENT OPINION IN UROLOGY, 2004, 14 (03) : 177 - 183
  • [49] Androgen deprivation therapy for metastatic salivary gland cancer
    Elkrief, Arielle
    Saleh, Ramy
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2018, 190 (33) : E985 - E987
  • [50] Androgen deprivation therapy for early prostate cancer
    Tanday, Sanjay
    LANCET ONCOLOGY, 2014, 15 (06): : E199 - E199